+Compare
TAK
Stock ticker: NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
49.93B

TAK Price Prediction, Takeda Pharmaceutical Company Limited AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for TAK with price predictions
08:00 PM EDT Sep 26, 2023

Momentum Indicator for TAK turns negative, indicating new downward trend

TAK saw its Momentum Indicator move below the 0 level on September 27, 2023. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned negative. In of the 87 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for TAK moved out of overbought territory on September 21, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for TAK turned negative on September 27, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TAK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TAK broke above its upper Bollinger Band on September 12, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

TAK moved above its 50-day moving average on September 11, 2023 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TAK crossed bullishly above the 50-day moving average on September 12, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TAK advanced for three days, in of 282 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 230 cases where TAK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.064) is normal, around the industry mean (85.806). P/E Ratio (24.752) is within average values for comparable stocks, (58.591). Projected Growth (PEG Ratio) (1.051) is also within normal values, averaging (3.373). Dividend Yield (0.021) settles around the average of (0.027) among similar stocks. P/S Ratio (1.812) is also within normal values, averaging (61.742).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TAK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TAK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

A.I. Advisor
published Earnings

TAK is expected to report earnings to fall 29.53% to 14 cents per share on October 26

Takeda Pharmaceutical Company Limited TAK Stock Earnings Reports
Q3'23
Est.
$0.14
Q2'23
Beat
by $0.06
Q1'23
Beat
by $0.02
Q4'22
Beat
by $0.01
Q3'22
Est.
$0.13
The last earnings report on July 27 showed earnings per share of 20 cents, beating the estimate of 14 cents. With 1.48M shares outstanding, the current market capitalization sits at 49.93B.
A.I.Advisor
published Dividends

TAK paid dividends on July 12, 2021

Takeda Pharmaceutical Company Limited TAK Stock Dividends
А dividend of $0.41 per share was paid with a record date of July 12, 2021, and an ex-dividend date of March 30, 2021. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 2.59B. The market cap for tickers in the group ranges from 246 to 81.81B. ZTS holds the highest valuation in this group at 81.81B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -2%. For the same Industry, the average monthly price growth was 38%, and the average quarterly price growth was 11%. CHHE experienced the highest price growth at 118%, while NEPT experienced the biggest fall at -64%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 10%. For the same stocks of the Industry, the average monthly volume growth was 143% and the average quarterly volume growth was 113%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 71
Price Growth Rating: 57
SMR Rating: 85
Profit Risk Rating: 92
Seasonality Score: -14 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a pharmaceutical products manufacturer

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1-1, Nihonbashi-Honcho 2-Chome
Phone
+81 332782306
Employees
49095
Web
https://www.takeda.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCOI64.340.49
+0.77%
Cogent Communications Holdings
SNFCA8.170.05
+0.62%
Security National Financial Corp
QCRH48.53-0.16
-0.33%
QCR Holdings
MTD1097.78-6.53
-0.59%
Mettler-Toledo International
MBIO2.11-0.15
-6.64%
Mustang Bio

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with RDY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then RDY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
-0.06%
RDY - TAK
39%
Loosely correlated
-0.27%
DVAX - TAK
31%
Poorly correlated
+1.76%
EVO - TAK
31%
Poorly correlated
-2.03%
PBH - TAK
30%
Poorly correlated
+1.41%
HLN - TAK
28%
Poorly correlated
-0.86%
More